Top

Clinical & Experimental Metastasis

Published in:

01-02-2003

KISS1 metastasis suppression and emergent pathways

Authors: John F. Harms, Danny R. Welch, Mary E. Miele

Published in: Clinical & Experimental Metastasis | Issue 1/2003

Title: KISS1 metastasis suppression and emergent pathways
Authors: John F. Harms
Danny R. Welch
Mary E. Miele
Publication date: 01-02-2003
Publisher: Kluwer Academic Publishers
Published in: Clinical & Experimental Metastasis / Issue 1/2003
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI: https://doi.org/10.1023/A:1022530100931

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 1/2003

Overexpression and functional alterations of the EphA2 tyrosine kinase in cancer

Breast cancer metastasis suppressor 1: Update

Introduction

Transcriptional regulation of osteopontin and the metastatic phenotype: Evidence for a Ras-activated enhancer in the human OPN promoter

Tumor metastasis-associated human MTA1 gene and its MTA1 protein product: Role in epithelial cancer cell invasion, proliferation and nuclear regulation

MKK4 and metastasis suppression: A marriage of signal transduction and metastasis research

Keynote webinar | Spotlight on antibody–drug conjugates in cancer